Affiliations 

  • 1 Hôpital Cardiologique du Haut-Lévêque, CHU Bordeaux, Université Bordeaux, IHU LIRYC, Bordeaux, France [email protected]
  • 2 Clinical Electrophysiology Department of Cardiology, Medical Centre, Hungarian Defence Forces, Budapest, Hungary
  • 3 Department of Cardiology, Linz General Hospital, Johannes Kepler University School of Medicine Linz, Linz, Austria
  • 4 Department of Cardiology, Kyorin University Hospital, Tokyo, Japan
  • 5 Electrophysiology and Pacing Unit, National Heart Institute, Kuala Lumpur, Malaysia
  • 6 Hospital Clínic, Universitat de Barcelona, Catalonia, Spain
  • 7 St Antonius Ziekenhuis, Nieuwegein, the Netherlands
  • 8 Academisch Medisch Centrum (AMC), Amsterdam, the Netherlands
  • 9 New York University, New York, NY, USA
  • 10 State Key Laboratory of Cardiovascular Disease Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • 11 Division of Electrophysiology, Department of Cardiology, CARE Hospitals and CARE Foundation, Hyderabad, India
  • 12 The Ohio State University, Columbus, OH, USA
  • 13 Emory University Hospital, Atlanta, GA, USA
  • 14 Catharina Ziekenhuis, Eindhoven, the Netherlands
  • 15 University of Pittsburgh Medical Center UPMC Presbyterian, Pittsburgh, PA, USA
  • 16 Medtronic plc, Mounds View, MN, USA
  • 17 Cardiovascular Section, University of Oklahoma Health Sciences Center, OU Medical Center, Oklahoma City, OK, USA
Eur Heart J, 2015 Oct 1;36(37):2510-9.
PMID: 26045305 DOI: 10.1093/eurheartj/ehv214

Abstract

Permanent cardiac pacing is the only effective treatment for symptomatic bradycardia, but complications associated with conventional transvenous pacing systems are commonly related to the pacing lead and pocket. We describe the early performance of a novel self-contained miniaturized pacemaker.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.